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Brooke-Spiegler syndrome (BSS; OMIM 605041), also known as familial cylindromatosis (OMIM 132700), is an autosomal dominant tumour predisposition disorder characterised by the occurrence of cylindromas, trichoepitheliomas, and spiradenomas. 1 BSS is caused by heterogenous mutations in the CYLD gene. To date, different CYLD mutations have been reported, most of them resulting in a premature termination codon (PTC). 2 Among these, thirteen splice site mutations have been described. 2, 3 However, it remains largely elusive how such mutations affect splicing. 2 Here, we studied three unrelated Caucasian patients with BSS who were initially diagnosed both clinically and histopathologically (Table 1) . To unequivocally confirm the diagnosis, we performed mutation analysis of the CYLD gene which revealed three splice site mutations. In order to select appropriate tissues for RNA studies, we assessed the expression of CYLD in normal human epidermal keratinocytes (NHEK), leukocytes and peripheral blood mononuclear cells (PBMC) by quantitative reverse transcriptase (qRT)-PCR. In all patients, residual mRNA levels were measured in RNA specimens derived from whole blood.
We detected three CYLD splice site mutations, designated c.2108+1G>A (Fig. 1a) , c.2242-2A>G (Fig. 1b) , and c.2109-2A>C (Fig. 1c) . These mutations were associated with distinct phenotypes, respectively (Table 1) . Interestingly, the first patient carried a novel mutation
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To study the role of nonsense-mediated mRNA decay in the three splice site mutations detected here, we measured CYLD mRNA expression in peripheral blood leukocytes by qRT-PCR. Whereas mutations c.2108+1G>A and c.2242-2A>G do not result in a significant decrease of mRNA levels, mutation c.2109-2A>C is associated with approximately 60% mRNA decay when compared to a control (Fig. 1d) .
The patient harbouring mutation c.2109-2A>C presented with cylindromas exclusively. This mutation has been previously reported in a family with trichoepitheliomas only, which suggests that the residual amounts of CYLD mRNA seem to be unrelated to the distinct phenotypes of individuals with this CYLD splice site defect. 4 To date, fifteen splice site
This article is protected by copyright. All rights reserved. Table 1 CYLD splice site mutations in this study, associated phenotypes, and the structural and functional consequences of these mutations. Table 1 CYLD splice site mutations in this study, associated phenotypes as well as the structural and functional consequences of these mutations.
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